Natural killer cell activity as a prognostic biomarker in non-small cell lung cancer patients treated with check-point inhibitors

S. W. C. Wen, T. S. Hansen, L. Nederby, R. F. Andersen, C. H. Nyhus, L. Bertelsen, B. T. Sorensen, H. Hager, O. Hilberg, A. Jakobsen, T. F. Hansen

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article number1323P
JournalAnnals of Oncology
Volume31
Issue numberSuppl. 4
Pages (from-to)S853
Number of pages1
ISSN0923-7534
DOIs
Publication statusPublished - 1. Sep 2020
EventESMO Virtual Congress -
Duration: 19. Sep 202018. Oct 2020

Conference

ConferenceESMO Virtual Congress
Period19/09/202018/10/2020

Cite this